Managed Care
Disease
Management

Biologics trend leads pharmaceuticals

MANAGED CARE September 2005. © MediMedia USA
Managed Care Outlook

Biologics trend leads pharmaceuticals

MANAGED CARE September 2005. ©MediMedia USA













The general stabilization in per-capita medical claims cost — what services cost the health plan before the member is charged — for the managed care industry has not, for the most part, spilled over to biologics, according to a survey by the Segal Co. The consulting company's ninth annual survey of health insurers, PBMs, and third-party administrators forecasts "continued declines in trends in 2006 for every coverage surveyed."

However, the company adds that, "the projected trend for biotechnology or specialty drugs is increasing at a rapid rate: 21.6 percent in 2006, approximately 8 percentage points above aggregate retail trend. The 2006 projection was obtained through a survey taken in summer 2005.

Burden of supplying pharmaceuticals, biologics

Note: No figures available for cost of biologics in 2004.

SOURCE: 2006 Segal Health Plan Cost Trend Survey.

Meetings

Medical Devices Summit Boston, MA February 19–20, 2015
3rd Annual Summit to Improve Adherence and Enhance Patient Engagement Philadelphia, PA March 9–10, 2015
Value-Added Solutions for Enhanced Customer Experience Philadelphia, PA March 9, 2015